ERBB2 and neoplasm: The clinico-pathological factors used in the current version (v2.2) are tumour size, tumour grade, number of positive lymph nodes, oestrogen receptor (ER) status, human epidermal growth factor receptor 2 (HER2) status, KI67 status and mode of detection [[1], [2], [3]].